Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care

References

• Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607.
   PubMed Web of Science ®Google Scholar
• Vidigal FC, Bressan J, Babio N, Salas-Salvadó J. Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC Public Health. 2013;13:1198. doi:10.1186/1471-2458-13-1198
   PubMedGoogle Scholar
• Aguilar M, Bhuket T, Torres S, Liu B, Wong R. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313:1973–1974.
   PubMed Web of Science ®Google Scholar
• Escobedo J, Schargrodsky H, Champagne B, et al. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc diabetol. 2009;9:1–9.
   Google Scholar
• Chen J, Muntner P, Hamm L, et al. The metabolic syndrome and chronic kidney disease in U.S.adults. Ann Intern Med. 2004;140:167–174. doi:10.7326/0003-4819-140-3-200402030-00007
   PubMed Web of Science ®Google Scholar
• Wilson PWF, Agostino RBD, Parise H, Sullivan L, Meigs JB. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. Cirulation. 2005;
   Google Scholar
• Sheng W, Zhong H, Suzanne L. Metabolic Syndrome and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies. Eur J Epidemiol. 2010;25(6):375–384. doi:10.1007/s10654-010-9459-z. 
   Google Scholar
• Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis. 2006;13:365–373. doi:10.1053/j.ackd.2006.07.011
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002;106:3144–3421.
   Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
   Web of Science ®Google Scholar
• Instituto Brasileiro de Geografia e Estatística - IBGE. Pesquisa De Orçamentos Familiares (POF) 2008-2009: Antropometria e Estado Nutricional De Crianças, Adolescentes e Adultos No Brasil. Rio de Janeiro: IBGE; 2009.
   Google Scholar
• Brasil. Ministério Da Saúde. Secretaria de Vigilancia em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. VIGITEL BRASIL 2017 - Vigilância De Fatores De Risco e Proteção Para Doenças Crônicas Por Inquérito Telefônico. Brasília: Ministério da Saúde; 2018. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/vigitel_2010_preliminar_web.pdf.
   Google Scholar
• Chen J, Kong X, Jia X, et al. Association between metabolic syndrome and chronic kidney disease in a Chinese urban population. Clin Chim Acta. 2017;470:103–108. doi:10.1016/j.cca.2017.05.012
   PubMedGoogle Scholar
• Huh JH, Yadav D, Kim JS, et al. An association of metabolic syndrome and chronic kidney disease from a 10-year prospective cohort study. Metabolism. 2017;67:54–61. doi:10.1016/j.metabol.2016.11.003
   PubMed Web of Science ®Google Scholar
• Mendy VL, Azevedo MJ, Sarpong DF, et al. The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study. PLoS One. 2014;9:1–7. doi:10.1371/journal.pone.0101610
   Google Scholar
• Lopes HF, Corrêa-Giannella ML, Consolim-Colombo FM, Egan BM. Visceral adiposity syndrome. Diabetol Metab Syndr. 2016;8:1–8. doi:10.1186/s13098-016-0156-2
   PubMedGoogle Scholar
• Trujillo J, Chirino Yolanda I, Martínez-Tagüeña N, Pedraza-Chaverri J. Renal damage in the metabolic syndrome (MetSx): disorders implicated. Eur J Pharmacol. 2018;818:554–568. doi:10.1016/j.ejphar.2017.11.032
   PubMedGoogle Scholar
• Stefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population. Kidney Int. 2018;93:1183–1190. doi:10.1016/j.kint.2017.11.012
   PubMedGoogle Scholar
• Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Physiol. 2016;311:F1087–F1108. doi:10.1152/ajprenal.00340.2016
   PubMed Web of Science ®Google Scholar
• Ding C, Yang Z, Wang S, Sun F, Zhan S. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study. Endocrine. 2018;60:282–291. doi:10.1007/s12020-018-1552-1
   PubMedGoogle Scholar
• Kwakernaak AJ, Zelle DM, Bakker SJL, Navis G. Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol. 2013;24:987–994. doi:10.1681/ASN.2012050460
   PubMedGoogle Scholar
• Burton JO, Gray LJ, Webb DR, et al. Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population. Nephrol Dial Transplant. 2012;27:1860–1866.
   PubMedGoogle Scholar
• Lee J, Kim HJ, Cho B, et al. Abdominal adipose tissue was associated with glomerular hyperfiltration among non-diabetic and normotensive adults with a normal body mass index. PLoS One. 2015;10:1–14.
   Google Scholar
• Pinto-Sietsma S-J, Navis G, Janssen WMT, de ZD, Gans ROB, De Jong PE. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41:733–741. doi:10.1016/S0272-6386(03)00020-9
   PubMed Web of Science ®Google Scholar
• McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36:14–20. doi:10.1016/j.clindermatol.2017.09.004
   PubMed Web of Science ®Google Scholar
• Gluba A, Mikhailidis DP, Lip GYH, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol. 2013;164:141–150. doi:10.1016/j.ijcard.2012.01.013
   PubMed Web of Science ®Google Scholar
• BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise de Situação de Saúde. Plano de ações estratégicas para o enfrentamenteo das Doenças Crônias Não Transmissíveis (DCNT) no Brasil 2011-2022; 2011. doi:10.1017/CBO9781107415324.004.
   Google Scholar
• NICE Clinical Guidelines 182. Chronic Kidney Disease: Early Iden- Tification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care. National Institute of Health and Care Excellence: London; 2014.
   Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   PubMed Web of Science ®Google Scholar
• Sesso RC, Lopes AA, Thomé FS, Lugon JR, Martins CT. Brazilian chronic dialysis survey 2016. J Bras Nefrol. 2017;39:261–266. doi:10.5935/0101-2800.20170049
   PubMedGoogle Scholar
• McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrol. 2019;30:127–135. doi:10.1681/ASN.2018050531
   PubMed Web of Science ®Google Scholar
• Kotsis V, Tsioufis K, Antza C, et al. Obesity and cardiovascular risk. J Hypertens. 2018;36:1441–1455. doi:10.1097/HJH.0000000000001731
   PubMedGoogle Scholar